Overall Mortality and LDL Cholesterol Reduction in Secondary Prevention Trials of Cardiovascular Disease

Juan Pedro-Botet1, Jose López-Miranda2, Lina Badimón3

  • 1Unitat de Lípids i Risc Vascular, Department of Medicine, Hospital del Mar, Universitat Autònoma de Barcelona, Passeig Marítim, 25-29, 08003, Barcelona, Spain. 86620@parcdesalutmar.cat.

Insights

Lipid-lowering therapies, including statins and non-statins, reduce cardiovascular events. While some trials show reduced overall mortality, only one demonstrated a significant decrease in all-cause mortality.

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Cardiovascular disease remains a leading cause of death globally.
  • Lipid-lowering therapies are crucial for managing cardiovascular risk.
  • Historically, mortality data have been underrepresented in major lipid trials.

Purpose of the Study:

  • To review and contrast mortality findings from key lipid-lowering trials.
  • To compare outcomes of statins versus placebo.
  • To evaluate intensive vs. moderate-intensity statin therapy and non-statin interventions.

Main Methods:

  • Narrative review of pooled data from randomized clinical trials.
  • Analysis of trials including statins, ezetimibe, and PCSK9 inhibitors.
  • Focus on cardiovascular events and overall/all-cause mortality.

Main Results:

  • Early trials (4S, LIPID, HPS) showed reduced overall mortality.
  • Intensified lipid lowering and non-statin therapies (ezetimibe, PCSK9 inhibitors) reduce cardiovascular events.
  • Only the ODYSSEY OUTCOMES trial demonstrated a reduction in all-cause mortality.

Conclusions:

  • While lipid lowering effectively reduces cardiovascular events, its impact on all-cause mortality varies.
  • Further investigation into therapies affecting all-cause mortality is warranted.
  • Trial design and patient populations influence observed mortality outcomes.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
286
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.3K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
554
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ...
1.8K
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
1.2K
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
530